Literature DB >> 2571515

Xenografting of fetal pig ventral mesencephalon corrects motor asymmetry in the rat model of Parkinson's disease.

T K Huffaker1, B D Boss, A S Morgan, N T Neff, R E Strecker, M S Spence, R Miao.   

Abstract

A suspension of cells from embryonic day 21 fetal pig ventral mesencephalon was transplanted into the striatum of 20 immunosuppressed rats with 6-hydroxydopamine-induced lesions of the nigrostriatal dopamine pathway. Of these rats, 15 showed reduction of amphetamine-induced ipsilateral rotation by 9 weeks and complete reversal of rotation by 14-17 weeks. Animals maintained stable reversal of rotations (contralateral direction) until cessation of Cyclosporin A (CyA) treatment at 15-20 weeks. Within 4-9 weeks after CyA removal, these rats showed exclusively ipsilateral rotations during behavioral testing which were comparable to pre-transplant levels, suggesting that the grafts were rejected upon cessation of CyA treatment. Rats were sacrificed and tyrosine hydroxylase (TH) immunohistochemistry was performed at several time points, both on and off CyA, to examine a possible correlation between the degree of rotational behavior and the number of TH-positive surviving grafted cells. Staining showed large numbers (230-12,329) of TH-positive surviving cells in animals displaying a high degree of rotational correction (1.6 to -9.6 net ipsilateral rotations/min) after cessation of CyA treatment. Two control groups, those transplanted with non-neuronal cells from the pig ventral mesencephalon (n = 5) and those receiving only daily CyA injections (n = 4) showed no significant reduction of net ipsilateral rotations throughout the experiment. No TH-positive surviving cells were seen in the one non-neuronal transplant analyzed. This data demonstrates long-term retention of xenografted tissue with immunosuppression and its concomitant restoration of normal motor behavior in the rat model of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2571515     DOI: 10.1007/BF00274990

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  27 in total

1.  Intracerebral grafting of dopamine neurons. Experimental basis for clinical trials in patients with Parkinson's disease.

Authors:  P Brundin; R E Strecker; O Lindvall; O Isacson; O G Nilsson; G Barbin; A Prochiantz; C Forni; A Nieoullon; H Widner
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  Intracephalic embryonic neural implants in the adult rat brain. I. Growth and mature organization of brainstem, cerebellar, and hippocampal implants.

Authors:  L F Kromer; A Björklund; U Stenevi
Journal:  J Comp Neurol       Date:  1983-08-20       Impact factor: 3.215

4.  Intracerebral grafting of neuronal cell suspensions. III. Activity of intrastriatal nigral suspension implants as assessed by measurements of dopamine synthesis and metabolism.

Authors:  R H Schmidt; A Björklund; U Stenevi; S B Dunnett; F H Gage
Journal:  Acta Physiol Scand Suppl       Date:  1983

5.  Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease.

Authors:  P Brundin; O G Nilsson; R E Strecker; O Lindvall; B Astedt; A Björklund
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

6.  Toxic effects of cyclosporine on the endocrine pancreas of Wistar rats.

Authors:  H J Hahn; F Laube; S Lucke; I Klöting; K D Kohnert; R Warzock
Journal:  Transplantation       Date:  1986-01       Impact factor: 4.939

7.  Restoration of dopaminergic function by grafting of fetal rat substantia nigra to the caudate nucleus: long-term behavioral, biochemical, and histochemical studies.

Authors:  W J Freed; M J Perlow; F Karoum; A Seiger; L Olson; B J Hoffer; R J Wyatt
Journal:  Ann Neurol       Date:  1980-11       Impact factor: 10.422

8.  Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release.

Authors:  P Brundin; R E Strecker; H Widner; D J Clarke; O G Nilsson; B Astedt; O Lindvall; A Björklund
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

9.  Human fetal substantia nigra grafted to the dopamine-denervated striatum of immunosuppressed rats: evidence for functional reinnervation.

Authors:  I Strömberg; M Bygdeman; M Goldstein; A Seiger; L Olson
Journal:  Neurosci Lett       Date:  1986-11-21       Impact factor: 3.046

10.  Improved liquid-chromatographic determination of cyclosporine, with concomitant detection of a cell-bound metabolite.

Authors:  G L Lensmeyer; B L Fields
Journal:  Clin Chem       Date:  1985-02       Impact factor: 8.327

View more
  4 in total

Review 1.  The immunological challenges of cell transplantation for the treatment of Parkinson's disease.

Authors:  Amanda L Piquet; Kala Venkiteswaran; Neena I Marupudi; Matthew Berk; Thyagarajan Subramanian
Journal:  Brain Res Bull       Date:  2012-04-11       Impact factor: 4.077

2.  Transplantation of expanded neural precursor cells from the developing pig ventral mesencephalon in a rat model of Parkinson's disease.

Authors:  Richard J E Armstrong; Pamela Tyers; Meena Jain; Andrew Richards; Stephen B Dunnett; Anne E Rosser; Roger A Barker
Journal:  Exp Brain Res       Date:  2003-06-03       Impact factor: 1.972

3.  Neural stem/progenitor cells as a promising candidate for regenerative therapy of the central nervous system.

Authors:  Virginie Bonnamain; Isabelle Neveu; Philippe Naveilhan
Journal:  Front Cell Neurosci       Date:  2012-04-11       Impact factor: 5.505

4.  Local control of the host immune response performed with mesenchymal stem cells: perspectives for functional intracerebral xenotransplantation.

Authors:  Xavier Lévêque; Elodie Mathieux; Véronique Nerrière-Daguin; Reynald Thinard; Laetitia Kermarrec; Tony Durand; Thomas Haudebourg; Bernard Vanhove; Laurent Lescaudron; Isabelle Neveu; Philippe Naveilhan
Journal:  J Cell Mol Med       Date:  2014-10-14       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.